COVID Clinical Trials in Washington D.C., District of Columbia
6 recruitingWashington D.C., District of Columbia
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Pfizer300 enrolled132 locationsNCT07013474
Recruiting
Phase 1
Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID)60 enrolled3 locationsNCT07183709
Recruiting
Phase 3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
COVID
University of Minnesota820 enrolled66 locationsNCT04910269
Recruiting
Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
COVID-19
BioNTech SE25,500 enrolled208 locationsNCT07300839
Recruiting
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
CoronavirusCOVIDRespiratory Infection
BioFire Defense LLC1,500 enrolled6 locationsNCT07221097
Recruiting
Phase 3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
COVID-19
Pfizer160 enrolled73 locationsNCT05261139